Obesity Is the Most Common Risk Factor for Chronic Liver Disease: Results From a Risk Stratification Pathway Using Transient Elastography
- PMID: 31453812
- DOI: 10.14309/ajg.0000000000000357
Obesity Is the Most Common Risk Factor for Chronic Liver Disease: Results From a Risk Stratification Pathway Using Transient Elastography
Abstract
Introduction: Obesity has been associated with liver fibrosis, yet guidelines do not emphasize it as an independent risk factor in which to have a high index of suspicion of advanced disease. We aimed to elucidate the effect of a raised body mass index on the risk of liver disease using data from a community risk stratification pathway.
Methods: We prospectively recruited patients from a primary care practice with hazardous alcohol use and/or type 2 diabetes and/or obesity. Subjects were invited for a transient elastography reading. A threshold of ≥8.0 kPa defined an elevated reading consistent with clinically significant liver disease.
Results: Five hundred seventy-six patients participated in the pathway; of which, 533 patients had a reliable reading and 66 (12.4%) had an elevated reading. Thirty-one percent of patients with an elevated reading had obesity as their only risk factor. The proportion of patients with an elevated reading was similar among those with obesity (8.9%) to patients with more recognized solitary risk factors (type 2 diabetes 10.8%; hazardous alcohol use 4.8%). Obesity in combination with other risk factors further increased the proportion of patients with an elevated reading. In multivariate logistic regression, increasing body mass index and type 2 diabetes were significantly associated with an elevated reading.
Discussion: Obesity as a single or additive risk factor for chronic liver disease is significant. Future case-finding strategies using a risk factor approach should incorporate obesity within proposed algorithms.
Comment in
-
The Impact of Obesity and Type 2 Diabetes on Chronic Liver Disease.Am J Gastroenterol. 2019 Nov;114(11):1714-1715. doi: 10.14309/ajg.0000000000000433. Am J Gastroenterol. 2019. PMID: 31599742
Similar articles
-
Obesity and type 2 diabetes are important risk factors underlying previously undiagnosed cirrhosis in general practice: a cross-sectional study using transient elastography.Aliment Pharmacol Ther. 2018 Feb;47(4):504-515. doi: 10.1111/apt.14463. Epub 2017 Dec 6. Aliment Pharmacol Ther. 2018. PMID: 29210096
-
Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography.BMJ Open. 2015 May 3;5(4):e007516. doi: 10.1136/bmjopen-2014-007516. BMJ Open. 2015. PMID: 25941185 Free PMC article.
-
Screening for hepatic fibrosis and steatosis in Turkish patients with type 2 diabetes mellitus: A transient elastography study.Turk J Gastroenterol. 2019 Mar;30(3):266-270. doi: 10.5152/tjg.2018.18559. Turk J Gastroenterol. 2019. PMID: 30411703 Free PMC article.
-
Detecting chronic liver disease: are liver function tests the solution?Br J Hosp Med (Lond). 2020 Feb 2;81(2):1-8. doi: 10.12968/hmed.2019.0308. Epub 2020 Feb 19. Br J Hosp Med (Lond). 2020. PMID: 32097065 Review.
-
Impact of diabetes on the severity of liver disease.Am J Med. 2007 Oct;120(10):829-34. doi: 10.1016/j.amjmed.2007.03.025. Am J Med. 2007. PMID: 17904449 Review.
Cited by
-
Liver at crossroads: unraveling the links between obesity, chronic liver diseases, and the mysterious obesity paradox.Clin Exp Med. 2024 Oct 14;24(1):240. doi: 10.1007/s10238-024-01493-y. Clin Exp Med. 2024. PMID: 39402270 Free PMC article. Review.
-
Early screening for chronic liver disease: impact of a FIB-4 first integrated care pathway to identify patients with significant fibrosis.Sci Rep. 2024 Sep 5;14(1):20720. doi: 10.1038/s41598-024-66210-x. Sci Rep. 2024. PMID: 39237521 Free PMC article.
-
A Noninvasive Scoring System for Liver Fibrosis in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease.Gastro Hep Adv. 2022 Jul 3;1(6):1006-1013. doi: 10.1016/j.gastha.2022.06.011. eCollection 2022. Gastro Hep Adv. 2022. PMID: 39131248 Free PMC article.
-
Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis.Clin Mol Hepatol. 2024 Sep;30(Suppl):S199-S213. doi: 10.3350/cmh.2024.0351. Epub 2024 Jul 30. Clin Mol Hepatol. 2024. PMID: 39074982 Free PMC article.
-
The Association between Educational Attainment and the Risk of Nonalcoholic Fatty Liver Disease among Chinese Adults: Findings from the REACTION Study.Gut Liver. 2024 Jul 15;18(4):719-728. doi: 10.5009/gnl230220. Epub 2024 Feb 22. Gut Liver. 2024. PMID: 38384199 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
